Benzo quinolin-3-one series compound is effective in the treatment of diseases of type I and type II 5α- reductase both caused.J·E·奥迪亚K·L·黑尔T·J·克雷斯L·A·麦奎德B·L·纽鲍尔V·P·罗科J·P·韦普斯克
The 5 alpha-reductase inhibitors shrink the prostate gland and include Proscar (finasteride) and Avodart (dutasteride). 5阿尔法-还原酶抑制剂能够缩小前列腺,这类药物包括普罗斯佳(finasteride)和度他雄胺dutasteride)。 article.yeeyan.org 2. Other drugs like Proscar and Avodart, called 5-alpha-reductase ...
aovulation 正在翻译,请等待...[translate] afertile 肥沃[translate] a5-alpha-reductase inhibitors (5-ARIs), finasteride and dutasteride, 5阿尔法还原酶抗化剂 (5-ARIs), finasteride和dutasteride,[translate]
Inhibitors of 5-alpha reductase block the activity of 5-alpha reductase, reducing the concentration of dihydrotestosterone in the blood and in the prostate tissue. A decrease in DHT production controls the growth of prostate tissue and reduces hair loss. How are 5-alpha reductase inhibitors used?
aPlease do not respond to this acknowledgment, as it has been automatically generated 因为它自动地引起了,不要反应这承认[translate] aPneumatic 气动力学[translate] aTESTOSTERONE-5-ALPHA REDUCTASE INHIBITORS TESTOSTERONE-5-ALPHA还原酶抗化剂[translate]...
5-alpha reductase inhibitors are used in benign prostate hyperplasia therapy, and it has been postulated that they may also be beneficial in preventive strategies for prostate cancer. Due to its dual effect on 5-alpha reductase inhibition, dutasteride may be preferred over finasteride for prostate ...
5'alpha'-REDUCTASE INHIBITORS. 来自 掌桥科研 喜欢 0 阅读量: 15 申请(专利)号: MX19970002035 申请日期: 1995-09-14 公开/公告号: MX9702035A 公开/公告日期: 1997-06-28 申请(专利权)人: ELI LILLY AND COMPANY 发明人: JAMES EDMUND AUDIA,LORETTA AMES MCQUAID,BLAKE LEE NEUBAUER,VINCENT PATRICK ...
While the chemoprotective effect of 5-alpha reductase inhibitors (5-ARi) on bladder cancer risk in men with Benign Prostatic Hyperplasia (BPH) has been explored with conflicting results, the evidence regarding 5-ARi treatment, and the risk of incident Upper Tract Urothelial Carcinoma (UTUC) ...
5α 还原酶 2 抑制剂包括非那雄胺 CAS 98319-26-7、度他雄胺 CAS 164656-23-9、α-雌二醇 CAS 57-91-0 和酮康唑 CAS 65277-42-1。
Novel substituted benzoyl benzoic acids and phenylacetic acids 1−14 have been synthesized and evaluated for inhibition of rat and human steroid 5α-reductase isozymes 1 and 2. The compounds turned out to be potent and selective human type 2 enzyme inhibitors, exhibiting IC50 values in the nanom...